Search Results 541-550 of 16952 for Conduction

1. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

   ... conduction system abnormalities. Prior to the first dose of study treatment, any electrocardiogram (ECG) abnormality at screening must be documented by the ...

2. A Dose Titration Study To Assess The Effects Of SAR407899 In Patients With Microvascular Angina And/or Persistent Stable Angina Despite Angiographically Successful Elective PCI - Mayo Clinic

   Patients with cardiac conduction abnormalities (second or third degree atrioventricular [AV] block, sick sinus syndrome, symptomatic bradycardia, sinus node ...

3. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   Clinically significant abnormalities detected on ECG of either rhythm or conduction, a QTcF > 450 ms, or a known long QT syndrome. Patients with implantable ...

4. Implantable cardioverter-defibrillators (ICDs) - Doctors & Departments - Mayo Clinic

   ... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Kevin T. Cragun, M.D.. Cardiologist. Areas of focus ...

5. Arthritis - Doctors and departments - Mayo Clinic

   ... conduction study, Neuromuscular ultrasound, Carpal tunnel syndrome, de Quervain's tenosynovitis, Peripheral nerve injury, Brachial plexus injury, Guillain ...

6. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   ... conduction system abnormalities;; Administration of a live, attenuated vaccine ≤ 4 weeks prior to registration or anticipation of a live attenuated vaccine ...

7. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

   ... conduction abnormalities. Clinically significant cardiac history or presence of ECG findings as judged by the Investigator or qualified designee at ...

8. Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery - Mayo Clinic

   Major conduction abnormality (unless a cardiac pacemaker is present); Patients with any cardiopulmonary symptoms of unknown cause (e.g., shortness of breath ...

9. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   Symptomatic congestive heart failure (i.e., Grade 2 or higher), history or current evidence of clinically significant cardiac arrhythmia and/or conduction ...

10. Physical Medicine and Rehabilitation - Doctors - Mayo Clinic

    ... conduction study, Neuromuscular ultrasound, Facet joint injection, Cyst aspiration, Sacroiliac joint injection, Neurophysiological assessment, Functional ...